New eye drops aim to soothe dry eyes in major trial

NCT ID NCT06717152

Completed Symptom relief Sponsor: Senju Pharmaceutical Science & Technology (Beijing) Co., Ltd. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This Phase 3 study tested SJP-0132 eye drops against placebo in 427 Chinese adults with dry eye disease. Participants used the drops four times daily for 8 weeks. The goal was to see if the drops improve eye surface damage and reduce dryness symptoms.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: SJP-0132 eye drops
What this could lead to: If successful, SJP-0132 could offer a new treatment option to relieve dry eye symptoms and improve eye surface health.
What could go wrong: This is a completed Phase 3 trial, but results are not yet published. The benefit over placebo may be modest, and individual responses can vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

dry eye syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DRY EYE

Contacts and locations

Locations

Affiliated Eye Hospital of Nanchang University

Nanchang, Jiangxi, China
Affiliated Hospital of Zunyi Medical University

Zunyi, Guizhou, China
Beijing Hospital

Beijing, Beijing Municipality, China
Beijing Tongren Hospital

Beijing, Beijing Municipality, China
Dalian No.3 People's Hospital

Dalian, Liaoning, China
Eye & ENT Hospital of Fudan University

Shanghai, Shanghai Municipality, China
Eye Hospital, WMU

Wenzhou, Zhejiang, China
Henan Eye Hospital

Zhengzhou, Henan, China
Joint Shantou International Eye Center of Shantou University and the Chinese University of Hong Kong

Shantou, Guangdong, China
Longhua Hospital Shanghai University of Traditional Chinese Medicine

Shanghai, Shanghai Municipality, China
Ningbo Eye Hospital

Ningbo, Zhejiang, China
Peking Union Medical College Hospital

Beijing, Beijing Municipality, China
Peking University Shenzhen Hospital

Shenzhen, Guangdong, China
People's Hospital of Hunan Province

Changsha, Hunan, China
Renmin Hospital of Wuhan University

Wuhan, Hubei, China
Shandong Eye Hospital

Jinan, Shandong, China
Shanxi Eye Hospital

Taiyuan, Shanxi, China
Shenzhen People's Hospital

Shenzhen, Guangdong, China
The Affiliated Hospital of Guizhou Medical University

Guiyang, Guizhou, China
The First Affiliated Hospital of University of South China

Hengyang, Hunan, China
The First Affiliated Hospital of Xi'an Jiaotong University

Xi'an, Shaanxi, China
The First Affiliated Hospital of Zhengzhou University

Zhengzhou, Henan, China
The First Bethune Hospital of Jilin University

Changchun, Jilin, China
The Fourth Affiliated Hospital of Soochow University

Suzhou, Jiangsu, China
The Fourth People's Hospital of Shenyang

Shenyang, Liaoning, China
The Second Norman Bethune Hospital of Jilin University

Changchun, Jilin, China
The first people's hospital of Xian Yang

Xianyang, Shanxi, China
Tianjin Medical University Ophthalmology Hospital

Tianjin, Tianjin Municipality, China
Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science & Technology

Wuhan, Hubei, China
Union Hospital Tongji Medical College Huazhong University of Science and Technology

Wuhan, Hubei, China
West China Hospital of Sichuan University

Chengdu, Sichuan, China
Xiamen Eye Center of Xiamen University

Xiamen, Fujian, China
Xiangya Hospital Central South University

Changsha, Hunan, China
Zhejiang Provincial People's Hospital

Hangzhou, Zhejiang, China
Zhongshan Ophthalmic Center, Sun Yat-sen University

Guangzhou, Guangdong, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.